Media Coverage

ImmuneRegen BioSciences Announces IND Submission for Homspera^® for the Treatment of Idiopathic Pulmonary Fibrosis

Genetic Engineering & Biotechnology News - May 28, 2009

BioTech Firm Gets Busy During Swine Flu’s “Summer Vacation”

BioSpace - May 21, 2009

Hollis-Eden Down On HHS Rejection of Radiation Drug

BioWorld Today - March 9, 2007

Drug Maker, Singapore Join For Study

The Business Journal - March 9, 2007

ImmuneRegen 'ripe' for a takeout; interested in ideas from bankers, CEO says

MergerMarket - March 7, 2007

Drug firm given shot in arm

Arizona Republic - Jan. 9, 2007

---

GENERAL INQUIRIES:

info@immuneregen.com

MEDIA CONTACT:

John N. Fermanis
Chief Financial Officer
ImmuneRegen BioSciences, Inc.
480-922-3926
jfermanis@immuneregen.com